We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+12.37%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$11.2B
AUM Growth
+$4.26B
Cap. Flow
+$3.84B
Cap. Flow %
34.3%
Top 10 Hldgs %
50.61%
Holding
1,169
New
360
Increased
131
Reduced
115
Closed
294

Sector Composition

Rank Sector Weight
1 Technology 17.31%
2 Healthcare 16.38%
3 Financials 13.99%
4 Communication Services 7.66%
5 Consumer Discretionary 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FACA.WS
801
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$96K ﹤0.01%
+75,000
New +$98.1K
MACUW
802
DELISTED
Mallard Acquisition Corp. Warrant
MACUW
$94K ﹤0.01%
199,993
LEAP.WS
803
DELISTED
Ribbit LEAP, Ltd. Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exer
LEAP.WS
$92K ﹤0.01%
39,999
RTPZ.WS
804
DELISTED
Reinvent Technology Partners Z Redeemable warrants, each whole warrant exercisable for one Class A o
RTPZ.WS
$91K ﹤0.01%
49,998
ZWRKW
805
DELISTED
Z-Work Acquisition Corp. Warrant
ZWRKW
$90K ﹤0.01%
+99,996
New +$77.2K
HCCCW
806
DELISTED
Healthcare Capital Corp. Warrant
HCCCW
$89K ﹤0.01%
124,996
PGRWW
807
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
$86K ﹤0.01%
124,996
CRZNW
808
DELISTED
Corazon Capital V838 Monoceros Corp Warrant
CRZNW
$86K ﹤0.01%
+83,659
New +$73K
OSTRW
809
DELISTED
Oyster Enterprises Acquisition Corp. Warrant
OSTRW
$86K ﹤0.01%
124,996
AENTW icon
810
Alliance Entertainment Holding Corp Warrants
AENTW
$4.27M
$85K ﹤0.01%
+124,996
New +$67.6K
TGI
811
PUT
DELISTED
Triumph Group
TGI
$85K ﹤0.01%
+103,400
New +$1.9M
OCAXW
812
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$85K ﹤0.01%
124,996
RRC icon
813
PUT
Range Resources
RRC
$8.96B
$83K ﹤0.01%
+35,400
New +$444K
ASPCW
814
DELISTED
Alpha Capital Acquisition Co Warrant
ASPCW
$83K ﹤0.01%
+100,000
New +$62.7K
HLAHW
815
DELISTED
Hamilton Lane Alliance Holdings I, Inc. Warrant
HLAHW
$81K ﹤0.01%
83,330
GLSPW
816
DELISTED
Global SPAC Partners Co. Warrants
GLSPW
$81K ﹤0.01%
+149,182
New +$58.4K
DCRNW
817
DELISTED
Decarbonization Plus Acquisition Corporation II Warrant
DCRNW
$80K ﹤0.01%
+54,998
New +$67K
MACAW
818
DELISTED
Moringa Acquisition Corp Warrant
MACAW
$79K ﹤0.01%
+100,000
New +$63.5K
SCOBW
819
DELISTED
ScION Tech Growth II Warrants
SCOBW
$79K ﹤0.01%
+83,330
New +$63.9K
TSIBW
820
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$77K ﹤0.01%
+60,000
New +$60.5K
RYAM icon
821
PUT
Rayonier Advanced Materials
RYAM
$611M
$73K ﹤0.01%
+126,800
New +$1.03M
WT icon
822
PUT
WisdomTree
WT
$3.22B
$70K ﹤0.01%
200,000
HCARW
823
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$69K ﹤0.01%
74,998
QFTA.WS
824
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$69K ﹤0.01%
199,993
BOAS.WS
825
DELISTED
BOA Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at a price of $11.50 per share
BOAS.WS
$69K ﹤0.01%
+83,333
New +$53.5K

Similar funds

UBS O'Connor's Q2 2021 Portfolio in Review

As of Q2 2021, UBS O'Connor held 1,169 positions worth $11.2B, up 61% from $6.94B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

UBS O'Connor deployed $3.84B of net new capital in Q2 2021, opening 360 new positions and adding to 131 existing holdings. Its largest new stake was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was MasTec, an estimated $7.65M trimmed.

  • UBS O'Connor's largest Q2 2021 buy was PPD, Inc. Common Stock: 14,271,048 shares worth $658M.
  • UBS O'Connor added most to Maxim Integrated Products in Q2 2021, an estimated $525M increase.
  • UBS O'Connor's biggest Q2 2021 reduction was MasTec, cutting an estimated $7.65M.
  • UBS O'Connor fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $475M.
  • UBS O'Connor's ten largest holdings make up 51% of its $11.2B portfolio in Q2 2021.
  • UBS O'Connor opened 360 new positions and closed 294 in Q2 2021.
  • UBS O'Connor's portfolio value rose 61% quarter-over-quarter to $11.2B.

Based on UBS O'Connor's 13F filing for Q2 2021, filed 13 Aug 2021.